Is Trulicity the same as dulaglutide?

Yes: Trulicity is the brand name for dulaglutide, the same once-weekly GLP-1 receptor agonist this site's profile lists as an alias. Approval is for type 2 diabetes. REWIND randomized 9,901 people, only about a third with prior cardiovascular disease, and found major events in 12.0% on dulaglutide versus 13.4% on placebo over a median 5.4 years. AWARD-6 found weekly dulaglutide 1.5 milligrams noninferior to daily liraglutide 1.8 milligrams on HbA1c at 26 weeks in 599 people. Weight reduction occurs but is generally smaller than with semaglutide or tirzepatide in their separate trials. This site does not rank the brands. Full record at /compounds/dulaglutide.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.